Hong Jiang

Dr. Hong Jiang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Pathology - Research and Practice
Verified
Journal Article
Closed access
CMChong Ma
Chong Ma
RJRi-Ming Jin
Ri-Ming Jin
KCKe-Ji Chen
Ke-Ji Chen
THTao Hao
Tao Hao
BLBao-Song Li
Bao-Song Li
HJHong Jiang
Hong Jiang

12 December 2025 in Medicine
Verified
Journal Article
Open access
GNGuo-Le Nie
Guo-Le Nie
SCShicheng Chu
Shicheng Chu
SGSong Geng
Song Geng
HJHong Jiang
Hong Jiang
HZHao Zhan
Hao Zhan
We report an 80-year-old male with a nodular fibrous pseudotumor (NFP), a rare benign tumor typically linked to trauma, surgery, or inflammation. Unusually, it presented as a mobile peritoneal loose body (PLB) despite no relevant abdominal history. Imaging showed a well-defined oval mass (70 × 63 mm). Pathological examination confirmed NFP, showing hyalinized collagen and fibroblast proliferation without atypia. This is the first NFP presenting as a PLB at our institution. The patient underwent successful laparoscopic resection with no recurrence during follow-up. This case highlights that: NFP can mimic mobile intraperitoneal lesions, requiring distinction from malignancy; pathological confirmation is essential due to overlapping computed tomography features with metastases; and the PLB presentation expands the known etiological spectrum beyond classical triggers. NFP should be considered in the differential diagnosis of peritoneal nodules, especially in atypical scenarios.

15 January 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
ZZZhirui Zhang
Zhirui Zhang
WSWenhuan Song
Wenhuan Song
WCWenyu Chen
Wenyu Chen
WCWenze Cui
Wenze Cui
WCWenyi Chen
Wenyi Chen
HJHong Jiang
Hong Jiang
Background and objective: MicroRNAs (miRNAs) are implicated in cancer by exerting roles in tumor growth, metastasis, and even drug resistance. The general trends of miRNA research in diverse cancers are not fully understood. In this work, miRNA-related research in colorectal cancer, prostate cancer, leukemia, and brain tumors was analyzed in search of key research trends with clinical potential.Methods: A bibliometric analysis of articles, spanning from 2014 to 2024, was carried out with the major focus laid on four types of cancers. The Co-citation network analysis, keyword bursts, and the collaborative pattern were done in VOSviewer and CiteSpace, respectively.Results: Colorectal cancer had the highest publication volume, with research primarily focusing on gene expression, extracellular vesicles, and non-coding RNAs. Prostate cancer showed a shift toward clinical applications, while leukemia and brain tumor research, though less extensive, highlighted miRNA’s potential in early diagnosis and treatment. Co-citation analysis identified emerging research collaborations and key contributors.Conclusion: miRNA plays a pivotal role in cancer diagnosis, biomarker development, and therapeutic interventions. With advancements in non-invasive diagnostics and personalized medicine, miRNA offers significant potential for clinical applications. Future research should focus on miRNA’s role in drug resistance and combination therapies to accelerate its clinical translation.